Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancer

  1. Robinson, B.G.
  2. Paz-Ares, L.
  3. Krebs, A.
  4. Vasselli, J.
  5. Haddad, R.
Aldizkaria:
Journal of Clinical Endocrinology and Metabolism

ISSN: 0021-972X 0021-972X

Argitalpen urtea: 2010

Alea: 95

Zenbakia: 6

Orrialdeak: 2664-2671

Mota: Artikulua

DOI: 10.1210/JC.2009-2461 GOOGLE SCHOLAR lock_openSarbide irekia editor